607 related articles for article (PubMed ID: 15578099)
1. GLUT4 glucose transporter deficiency increases hepatic lipid production and peripheral lipid utilization.
Kotani K; Peroni OD; Minokoshi Y; Boss O; Kahn BB
J Clin Invest; 2004 Dec; 114(11):1666-75. PubMed ID: 15578099
[TBL] [Abstract][Full Text] [Related]
2. Adipose-specific overexpression of GLUT4 reverses insulin resistance and diabetes in mice lacking GLUT4 selectively in muscle.
Carvalho E; Kotani K; Peroni OD; Kahn BB
Am J Physiol Endocrinol Metab; 2005 Oct; 289(4):E551-61. PubMed ID: 15928024
[TBL] [Abstract][Full Text] [Related]
3. Glucose toxicity and the development of diabetes in mice with muscle-specific inactivation of GLUT4.
Kim JK; Zisman A; Fillmore JJ; Peroni OD; Kotani K; Perret P; Zong H; Dong J; Kahn CR; Kahn BB; Shulman GI
J Clin Invest; 2001 Jul; 108(1):153-60. PubMed ID: 11435467
[TBL] [Abstract][Full Text] [Related]
4. High level overexpression of glucose transporter-4 driven by an adipose-specific promoter is maintained in transgenic mice on a high fat diet, but does not prevent impaired glucose tolerance.
Gnudi L; Tozzo E; Shepherd PR; Bliss JL; Kahn BB
Endocrinology; 1995 Mar; 136(3):995-1002. PubMed ID: 7867610
[TBL] [Abstract][Full Text] [Related]
5. Peripheral but not hepatic insulin resistance in mice with one disrupted allele of the glucose transporter type 4 (GLUT4) gene.
Rossetti L; Stenbit AE; Chen W; Hu M; Barzilai N; Katz EB; Charron MJ
J Clin Invest; 1997 Oct; 100(7):1831-9. PubMed ID: 9312184
[TBL] [Abstract][Full Text] [Related]
6. Adipose-selective targeting of the GLUT4 gene impairs insulin action in muscle and liver.
Abel ED; Peroni O; Kim JK; Kim YB; Boss O; Hadro E; Minnemann T; Shulman GI; Kahn BB
Nature; 2001 Feb; 409(6821):729-33. PubMed ID: 11217863
[TBL] [Abstract][Full Text] [Related]
7. Metabolic fuel selection: the importance of being flexible.
Bickel PE
J Clin Invest; 2004 Dec; 114(11):1547-9. PubMed ID: 15578087
[TBL] [Abstract][Full Text] [Related]
8. Targeted disruption of the glucose transporter 4 selectively in muscle causes insulin resistance and glucose intolerance.
Zisman A; Peroni OD; Abel ED; Michael MD; Mauvais-Jarvis F; Lowell BB; Wojtaszewski JF; Hirshman MF; Virkamaki A; Goodyear LJ; Kahn CR; Kahn BB
Nat Med; 2000 Aug; 6(8):924-8. PubMed ID: 10932232
[TBL] [Abstract][Full Text] [Related]
9. Calorie restriction improves whole-body glucose disposal and insulin resistance in association with the increased adipocyte-specific GLUT4 expression in Otsuka Long-Evans Tokushima fatty rats.
Park SY; Choi GH; Choi HI; Ryu J; Jung CY; Lee W
Arch Biochem Biophys; 2005 Apr; 436(2):276-84. PubMed ID: 15797240
[TBL] [Abstract][Full Text] [Related]
10. Prevention of insulin resistance and diabetes in mice heterozygous for GLUT4 ablation by transgenic complementation of GLUT4 in skeletal muscle.
Tsao TS; Stenbit AE; Factor SM; Chen W; Rossetti L; Charron MJ
Diabetes; 1999 Apr; 48(4):775-82. PubMed ID: 10102694
[TBL] [Abstract][Full Text] [Related]
11. Variation in type 2 diabetes--related traits in mouse strains susceptible to diet-induced obesity.
Rossmeisl M; Rim JS; Koza RA; Kozak LP
Diabetes; 2003 Aug; 52(8):1958-66. PubMed ID: 12882911
[TBL] [Abstract][Full Text] [Related]
12. Gene expression of GLUT4 in skeletal muscle from insulin-resistant patients with obesity, IGT, GDM, and NIDDM.
Garvey WT; Maianu L; Hancock JA; Golichowski AM; Baron A
Diabetes; 1992 Apr; 41(4):465-75. PubMed ID: 1535055
[TBL] [Abstract][Full Text] [Related]
13. Adipose tissue selective insulin receptor knockout protects against obesity and obesity-related glucose intolerance.
Blüher M; Michael MD; Peroni OD; Ueki K; Carter N; Kahn BB; Kahn CR
Dev Cell; 2002 Jul; 3(1):25-38. PubMed ID: 12110165
[TBL] [Abstract][Full Text] [Related]
14. Nonobese, insulin-deficient Ins2Akita mice develop type 2 diabetes phenotypes including insulin resistance and cardiac remodeling.
Hong EG; Jung DY; Ko HJ; Zhang Z; Ma Z; Jun JY; Kim JH; Sumner AD; Vary TC; Gardner TW; Bronson SK; Kim JK
Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1687-96. PubMed ID: 17911348
[TBL] [Abstract][Full Text] [Related]
15. In vitro analysis of the glucose-transport system in GLUT4-null skeletal muscle.
Ryder JW; Kawano Y; Chibalin AV; Rincón J; Tsao TS; Stenbit AE; Combatsiaris T; Yang J; Holman GD; Charron MJ; Zierath JR
Biochem J; 1999 Sep; 342 ( Pt 2)(Pt 2):321-8. PubMed ID: 10455018
[TBL] [Abstract][Full Text] [Related]
16. Syntaxin 4 heterozygous knockout mice develop muscle insulin resistance.
Yang C; Coker KJ; Kim JK; Mora S; Thurmond DC; Davis AC; Yang B; Williamson RA; Shulman GI; Pessin JE
J Clin Invest; 2001 May; 107(10):1311-8. PubMed ID: 11375421
[TBL] [Abstract][Full Text] [Related]
17. Lilly lecture 1995. Glucose transport: pivotal step in insulin action.
Kahn BB
Diabetes; 1996 Nov; 45(11):1644-54. PubMed ID: 8866574
[TBL] [Abstract][Full Text] [Related]
18. Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes.
Yang Q; Graham TE; Mody N; Preitner F; Peroni OD; Zabolotny JM; Kotani K; Quadro L; Kahn BB
Nature; 2005 Jul; 436(7049):356-62. PubMed ID: 16034410
[TBL] [Abstract][Full Text] [Related]
19. Cardiac and adipose tissue abnormalities but not diabetes in mice deficient in GLUT4.
Katz EB; Stenbit AE; Hatton K; DePinho R; Charron MJ
Nature; 1995 Sep; 377(6545):151-5. PubMed ID: 7675081
[TBL] [Abstract][Full Text] [Related]
20. PKCλ haploinsufficiency prevents diabetes by a mechanism involving alterations in hepatic enzymes.
Sajan MP; Ivey RA; Lee M; Mastorides S; Jurczak MJ; Samuels VT; Shulman GI; Braun U; Leitges M; Farese RV
Mol Endocrinol; 2014 Jul; 28(7):1097-107. PubMed ID: 24877563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
